It's trending up. Investors like that. It will keep trending up until it doesn't. All I'm sure of is that 10 will soon be support rather than resistance. There will be no reason for VTL to be in single digits for quite some time.
Calling the device "dangerous" is over the top. While the subjects of prior trials who didn't respond well to the device may have fared better with a more typical treatment, we're talking about a matter of a few days. The device was their best chance for longer- term survival, and they signed up for the trial in hopes of achieving just that. The detractors make it sound like healthy people are being killed by this device. In truth, almost dead people died. The other treatments would have bought a few more days at best. We're talking about people who need a liver transplant, and there are not enough livers to go around. This is why every effort is being made to see whom ELAD will benefit, with the FDA's blessing. Success is necessary!
News 
Market Data 
Discover 
